These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Determination of gamma glutamyl transpeptidase activity in human serum. Its use in oncology. Delarue JC; Sancho H; Rouesse J; Bohuon C Biomedicine; 1973 Mar; 18(2):152-8. PubMed ID: 4147288 [No Abstract] [Full Text] [Related]
23. The value of liver function tests in hepatocellular carcinoma. Lopez JB; Balasegaram M; Thambyrajah V; Timor J Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229 [TBL] [Abstract][Full Text] [Related]
24. Elevated alpha-fetoprotein levels in hepatocellular carcinoma. Yao FY Am J Gastroenterol; 1999 Nov; 94(11):3387. PubMed ID: 10566766 [No Abstract] [Full Text] [Related]
25. The beneficial effects of anisodamine for CyA hepatotoxicity in the rat and in renal-transplant recipients. Wang X; Tang X; Xie T; Sun X Transplant Proc; 1997; 29(1-2):286-7. PubMed ID: 9122998 [No Abstract] [Full Text] [Related]
26. Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma. Aita P; Robieux I; Sorio R; Tumolo S; Corona G; Cannizzaro R; Colussi AM; Boiocchi M; Toffoli G Cancer Chemother Pharmacol; 1999; 43(4):287-94. PubMed ID: 10071979 [TBL] [Abstract][Full Text] [Related]
27. Primary leiomyosarcoma of the liver. Wilson SE; Braitman H; Plested WG; Longmire WP Ann Surg; 1971 Aug; 174(2):232-7. PubMed ID: 5560846 [No Abstract] [Full Text] [Related]
28. Estimation of functional reserve of normal and regenerating dog livers. Rikkers LF; Moody FG Surgery; 1974 Mar; 75(3):421-9. PubMed ID: 4811338 [No Abstract] [Full Text] [Related]
29. Clinical, pathologic, and therapeutic aspects of carcinoma of the pancreas. Collure DW; Burns GP; Schenk WG Am J Surg; 1974 Nov; 128(5):683-9. PubMed ID: 4140697 [No Abstract] [Full Text] [Related]
31. Metabolism of drugs and carcinogens in man: antipyrine elimination as an indicator. Kalamegham R; Krishnaswamy K; Krishnamurthy S; Bhargava RN Clin Pharmacol Ther; 1979 Jan; 25(1):67-73. PubMed ID: 31258 [TBL] [Abstract][Full Text] [Related]
32. Therapy for carcinoma of the liver. Bloomenthal ED; Spellberg MA Am J Gastroenterol; 1971 Oct; 56(4):334-45. PubMed ID: 4330120 [No Abstract] [Full Text] [Related]
33. Differences in the rate of ethanol metabolism in recently drinking alcoholic and nondrinking subjects. Kater RM; Carulli N; Iber FL Am J Clin Nutr; 1969 Dec; 22(12):1608-17. PubMed ID: 5362487 [No Abstract] [Full Text] [Related]
35. Primary biliary cirrhosis treated with low-dose oral pulse methotrexate. Kaplan MM; Knox TA; Arora SA Ann Intern Med; 1988 Sep; 109(5):429-31. PubMed ID: 3408057 [No Abstract] [Full Text] [Related]
36. A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Primack A; Vogel CL; Kyalwazi SK; Ziegler JL; Simon R; Anthony PP Cancer; 1975 May; 35(5):1357-64. PubMed ID: 47261 [TBL] [Abstract][Full Text] [Related]
37. Lactic dehydrogenase isoenzyme alterations in malignant disease of the liver. Massey WH; Dennis DL; Fletcher WS; Wood DC Am J Surg; 1971 Aug; 122(2):209-16. PubMed ID: 4327173 [No Abstract] [Full Text] [Related]
38. Comparative metabolism of benzo[a]pyrene and drugs in human liver. Kapitulnik J; Popper PJ; Conney AH Clin Pharmacol Ther; 1977 Feb; 21(2):166-76. PubMed ID: 837635 [TBL] [Abstract][Full Text] [Related]
39. Partial hepatectomy on cirrhotic liver with a right lateral tumor. Lee CS; Chao CC; Lin TY Surgery; 1985 Nov; 98(5):942-8. PubMed ID: 2997944 [TBL] [Abstract][Full Text] [Related]